FREDESVINDA JACOBS-ALVAREZ: Open Payments
NPI 1063468668 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 47 payments from 18 companies in 2025. Trend: 2023 $1,791 · 2024 $2,460 · 2025 $1,835
Food & beverage: $1,760Debt forgiveness: $75
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $332 |
| Neurocrine BioSciences, Inc. | 8 | $262 |
| E.R. Squibb & Sons, L.L.C. | 4 | $237 |
| Janssen Pharmaceuticals, Inc | 5 | $211 |
| Teva Pharmaceuticals USA, Inc. | 4 | $172 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| Neuronetics, Inc. | 1 | $75 |
| Bausch Health US, LLC | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
Products named: CAPLYTA, INGREZZA, COBENFY, SPRAVATO, AUSTEDO XR, REXULTI, Auvelity, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across FL — which companies pay providers there.
